107 related articles for article (PubMed ID: 4219006)
1. A hematologist's appraisal of the problem cerebral lymphomas in transplanted patients. A speculative review.
Marmont AM
Haematologica; 1974 Dec; 59(4):489-98. PubMed ID: 4219006
[No Abstract] [Full Text] [Related]
2. [Malignant tumors under immunosuppression, a new problem in transplant-recipients].
Enderlin F; Guisan Y
Helv Chir Acta; 1973 Dec; 40(5):773-6. PubMed ID: 4589045
[No Abstract] [Full Text] [Related]
3. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
4. An overview of cancer immunology.
Ritts RE; Neel HB
Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
[No Abstract] [Full Text] [Related]
5. [Lymphomata in patients with kidney transplantation].
Robinson E; Better O
Harefuah; 1972 May; 82(10):474-5. PubMed ID: 4564550
[No Abstract] [Full Text] [Related]
6. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
7. [A case of malignant lymphoma after renal transplantation].
Oyama H; Yamao K; Sugiyama T; Matsuura O; Murakami S; Ikeda K; Inoue S
No Shinkei Geka; 1997 Jul; 25(7):655-60. PubMed ID: 9218261
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression and malignancy.
Br Med J; 1972 Sep; 3(5829):713-4. PubMed ID: 4562175
[No Abstract] [Full Text] [Related]
9. Malignancy and immunosuppression.
Kinlen LJ
Proc R Soc Med; 1972 Mar; 65(3):242. PubMed ID: 4563298
[No Abstract] [Full Text] [Related]
10. [Immunosuppression mechanism affecting the development of neoplasms].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
[No Abstract] [Full Text] [Related]
11. [Primary central nervous system lymphoma in a patient with systemic lupus erythematosus].
Pisoni CN; Grinberg AR; Plana JL; Freue RD; Manni JA; Paz L
Medicina (B Aires); 2003; 63(3):221-3. PubMed ID: 12876906
[TBL] [Abstract][Full Text] [Related]
12. Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies.
Bichile T; Petri M
Curr Opin Rheumatol; 2014 Mar; 26(2):111-7. PubMed ID: 24419748
[TBL] [Abstract][Full Text] [Related]
13. Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.
Lipsmeyer EA
Arthritis Rheum; 1972; 15(2):183-6. PubMed ID: 4554891
[No Abstract] [Full Text] [Related]
14. [Immunodeficiency and lymphomas].
Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
[No Abstract] [Full Text] [Related]
15. [Immunology of tumors].
Surján L
Orv Hetil; 1969 Aug; 110(31):1777-82. PubMed ID: 4898067
[No Abstract] [Full Text] [Related]
16. Transplantation antigens and viral carcinogenesis.
Haughton G; Nash DR
Prog Med Virol; 1969; 11():248-306. PubMed ID: 4906871
[No Abstract] [Full Text] [Related]
17. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
Végso G
Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
[TBL] [Abstract][Full Text] [Related]
18. The recognition of drug effects.
Decker JL
Arthritis Rheum; 1972; 15(2):187-8. PubMed ID: 4554892
[No Abstract] [Full Text] [Related]
19. Selected problems in immunosuppressive therapy.
Rondio H
Mater Med Pol; 1974; 6(1):34-40. PubMed ID: 4613962
[No Abstract] [Full Text] [Related]
20. [Pathogenesis of lymphoreticular neoplasms in transplant recipients].
Krüger G
Verh Dtsch Ges Pathol; 1970; 54():175-81. PubMed ID: 4104526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
